These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
Delaware
|
|
20-1446869
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
2300 Orchard Parkway, San Jose, California 95131
|
||
|
(Address of Principal Executive Offices and Zip Code)
|
||
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.00001 par value
|
|
ATEN
|
|
New York Stock Exchange
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
|
|
Emerging growth company
|
¨
|
|
|
|
A10 NETWORKS, INC.
FORM 10-Q
TABLE OF CONTENTS
|
|
|
|
Page No.
|
|
|
|
|
•
|
the ultimate impact of the COVID-19 pandemic on our business, results of operations, financial position and liquidity;
|
|
•
|
our ability to provide customers with improved benefits relating to their applications;
|
|
•
|
our ability to maintain an adequate rate of revenue growth and other factors contributing to such growth;
|
|
•
|
our ability to successfully anticipate market needs and opportunities;
|
|
•
|
our business plan and our ability to effectively manage our growth;
|
|
•
|
our plans to expand and strengthen our sales efforts;
|
|
•
|
our expectations with respect to recognizing revenue related to remaining performance obligations;
|
|
•
|
our plans to introduce new products;
|
|
•
|
loss or delay of expected purchases by our largest end-customers;
|
|
•
|
our ability to further penetrate our existing customer base;
|
|
•
|
our ability to displace existing products in established markets;
|
|
•
|
continued growth in markets relating to network security;
|
|
•
|
our ability to timely and effectively scale and adapt our existing technology;
|
|
•
|
our ability to innovate new products and bring them to market in a timely manner;
|
|
•
|
our ability to expand internationally and any related impact on profitability;
|
|
•
|
the effects of increased competition in our market and our ability to compete effectively;
|
|
•
|
the effects of seasonal trends on our results of operations;
|
|
•
|
our expectations concerning relationships with third parties;
|
|
•
|
our expectations with respect to the realization of our tax assets and our unrecognized tax benefits;
|
|
•
|
our plans with respect to the repatriation of our earnings from our foreign operations;
|
|
•
|
the attraction, retention and growth of qualified employees and key personnel;
|
|
•
|
our ability to achieve or maintain profitability while continuing to invest in our sales, marketing, product development, distribution channel partner programs and research and development teams;
|
|
•
|
our expectations regarding our future expenses;
|
|
•
|
our expectations with respect to restructuring actions and expenses;
|
|
•
|
our expectations with respect to liquidity position and future capital requirements;
|
|
•
|
our exploration of strategic alternatives;
|
|
•
|
variations in product mix or geographic locations of our sales;
|
|
•
|
fluctuations in currency exchange rates;
|
|
•
|
tariffs affecting us;
|
|
•
|
increased cost requirements of being a public company and future sales of substantial amounts of our common stock in the public markets;
|
|
•
|
the cost and potential outcomes of litigation;
|
|
•
|
our ability to maintain, protect, and enhance our brand and intellectual property;
|
|
•
|
future acquisitions of or investments in complementary companies, products, services or technologies; and
|
|
•
|
our ability to effectively integrate operations of entities we have acquired or may acquire.
|
|
•
|
Implemented work-from-home and social distancing policies for our organization;
|
|
•
|
Taken steps to ensure employee’s ability to remotely work-from-home when feasible;
|
|
•
|
Continue to maintain our focus on improving profitability; and
|
|
•
|
Continue to monitor our supply chain closely.
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
ASSETS
|
|||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
65,633
|
|
|
$
|
45,742
|
|
|
Marketable securities
|
77,273
|
|
|
84,180
|
|
||
|
Accounts receivable, net of allowances of $267 and $52, respectively
|
42,862
|
|
|
53,566
|
|
||
|
Inventory
|
20,764
|
|
|
22,384
|
|
||
|
Prepaid expenses and other current assets
|
12,518
|
|
|
15,067
|
|
||
|
Total current assets
|
219,050
|
|
|
220,939
|
|
||
|
Property and equipment, net
|
7,462
|
|
|
7,656
|
|
||
|
Goodwill
|
1,307
|
|
|
1,307
|
|
||
|
Intangible assets
|
1,944
|
|
|
2,305
|
|
||
|
Other non-current assets
|
40,294
|
|
|
41,846
|
|
||
|
Total assets
|
$
|
270,057
|
|
|
$
|
274,053
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
3,937
|
|
|
$
|
7,592
|
|
|
Accrued liabilities
|
24,243
|
|
|
27,756
|
|
||
|
Deferred revenue
|
62,718
|
|
|
62,233
|
|
||
|
Total current liabilities
|
90,898
|
|
|
97,581
|
|
||
|
Deferred revenue, non-current
|
38,560
|
|
|
38,931
|
|
||
|
Other non-current liabilities
|
27,347
|
|
|
28,754
|
|
||
|
Total liabilities
|
156,805
|
|
|
165,266
|
|
||
|
Commitments and contingencies (Note 2 and Note 5)
|
|
|
|
||||
|
Stockholders' equity:
|
|||||||
|
Common stock, $0.00001 par value: 500,000 shares authorized; 78,710 and 77,580 shares issued and outstanding, respectively
|
1
|
|
|
1
|
|
||
|
Additional paid-in-capital
|
403,650
|
|
|
398,600
|
|
||
|
Accumulated other comprehensive income (loss)
|
(37
|
)
|
|
251
|
|
||
|
Accumulated deficit
|
(290,362
|
)
|
|
(290,065
|
)
|
||
|
Total stockholders' equity
|
113,252
|
|
|
108,787
|
|
||
|
Total liabilities and stockholders' equity
|
$
|
270,057
|
|
|
$
|
274,053
|
|
|
|
|
|
|
||||
|
|
Three Months Ended
March 31, |
||||||
|
|
2020
|
|
2019
|
||||
|
Revenue:
|
|
|
|
|
|
||
|
Products
|
$
|
30,736
|
|
|
$
|
28,230
|
|
|
Services
|
23,028
|
|
|
22,060
|
|
||
|
Total revenue
|
53,764
|
|
|
50,290
|
|
||
|
Cost of revenue:
|
|
|
|
||||
|
Products
|
6,941
|
|
|
7,516
|
|
||
|
Services
|
5,201
|
|
|
4,734
|
|
||
|
Total cost of revenue
|
12,142
|
|
|
12,250
|
|
||
|
Gross profit
|
41,622
|
|
|
38,040
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
Sales and marketing
|
20,621
|
|
|
24,483
|
|
||
|
Research and development
|
15,315
|
|
|
16,166
|
|
||
|
General and administrative
|
5,895
|
|
|
8,358
|
|
||
|
Total operating expenses
|
41,831
|
|
|
49,007
|
|
||
|
Loss from operations
|
(209
|
)
|
|
(10,967
|
)
|
||
|
Non-operating income (expense):
|
|
|
|
||||
|
Interest expense
|
—
|
|
|
(155
|
)
|
||
|
Interest and other income (expense), net
|
231
|
|
|
(633
|
)
|
||
|
Total non-operating income (expense), net
|
231
|
|
|
(788
|
)
|
||
|
Income (loss) before provision for income taxes
|
22
|
|
|
(11,755
|
)
|
||
|
Provision for income taxes
|
319
|
|
|
517
|
|
||
|
Net loss
|
$
|
(297
|
)
|
|
$
|
(12,272
|
)
|
|
Net loss per share:
|
|
|
|
||||
|
Basic
|
$
|
0.00
|
|
|
$
|
(0.16
|
)
|
|
Diluted
|
$
|
0.00
|
|
|
$
|
(0.16
|
)
|
|
Weighted-average shares used in computing net loss per share:
|
|
|
|
||||
|
Basic
|
78,061
|
|
|
74,809
|
|
||
|
Diluted
|
78,061
|
|
|
74,809
|
|
||
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
Net loss
|
$
|
(297
|
)
|
|
$
|
(12,272
|
)
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
|
Unrealized gain (loss) on marketable securities
|
(288
|
)
|
|
240
|
|
||
|
Comprehensive loss
|
$
|
(585
|
)
|
|
$
|
(12,032
|
)
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
|
2020
|
|
2019
|
||||
|
Shares of common stock issued and outstanding
|
|
|
|
||||||
|
|
Beginning balance at December 31, 2019 and 2018, respectively
|
77,580
|
|
|
74,301
|
|
|||
|
|
Common stock issued under employee equity incentive plans
|
1,130
|
|
|
882
|
|
|||
|
|
|
Ending balance
|
78,710
|
|
|
75,183
|
|
||
|
|
|
|
|
|
|
||||
|
Stockholders' equity
|
|
|
|
||||||
|
|
Beginning balance at December 31, 2019 and 2018, respectively
|
$
|
108,787
|
|
|
$
|
103,883
|
|
|
|
|
Common stock:
|
|
|
|
|||||
|
|
|
Beginning balance
|
$
|
1
|
|
|
$
|
1
|
|
|
|
|
Common stock issued under employee equity incentive plans
|
—
|
|
|
—
|
|
||
|
|
|
Ending balance
|
$
|
1
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
||||
|
|
Additional paid-in capital:
|
|
|
|
|||||
|
|
|
Beginning balance
|
$
|
398,600
|
|
|
$
|
376,272
|
|
|
|
|
Common stock issued under employee equity incentive plans
|
2,005
|
|
|
1,027
|
|
||
|
|
|
Stock-based compensation
|
3,045
|
|
|
3,896
|
|
||
|
|
|
Ending balance
|
$
|
403,650
|
|
|
$
|
381,195
|
|
|
|
|
|
|
|
|
||||
|
|
Accumulated other comprehensive income (loss):
|
|
|
|
|||||
|
|
|
Beginning balance
|
$
|
251
|
|
|
$
|
(144
|
)
|
|
|
|
Unrealized gain (loss) on marketable securities, net of tax
|
(288
|
)
|
|
240
|
|
||
|
|
|
Ending balance
|
$
|
(37
|
)
|
|
$
|
96
|
|
|
|
|
|
|
|
|
||||
|
|
Accumulated deficit:
|
|
|
|
|||||
|
|
|
Beginning balance
|
$
|
(290,065
|
)
|
|
$
|
(272,246
|
)
|
|
|
|
Net loss
|
(297
|
)
|
|
(12,272
|
)
|
||
|
|
|
Ending balance
|
$
|
(290,362
|
)
|
|
$
|
(284,518
|
)
|
|
|
|
|
|
|
|
||||
|
Total stockholders' equity
|
$
|
113,252
|
|
|
$
|
96,774
|
|
||
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||
|
Net loss
|
$
|
(297
|
)
|
|
$
|
(12,272
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
3,311
|
|
|
2,447
|
|
||
|
Stock-based compensation
|
3,040
|
|
|
3,896
|
|
||
|
Other non-cash items
|
(13
|
)
|
|
(246
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
10,767
|
|
|
9,285
|
|
||
|
Inventory
|
1,472
|
|
|
(3,325
|
)
|
||
|
Prepaid expenses and other assets
|
2,426
|
|
|
(2,409
|
)
|
||
|
Accounts payable
|
(3,718
|
)
|
|
(492
|
)
|
||
|
Accrued and other liabilities
|
(4,919
|
)
|
|
(3,616
|
)
|
||
|
Deferred revenue
|
114
|
|
|
603
|
|
||
|
Other
|
—
|
|
|
71
|
|
||
|
Net cash provided by (used in) operating activities
|
12,183
|
|
|
(6,058
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Proceeds from sales of marketable securities
|
1,914
|
|
|
8,674
|
|
||
|
Proceeds from maturities of marketable securities
|
10,175
|
|
|
4,500
|
|
||
|
Purchases of marketable securities
|
(5,518
|
)
|
|
(13,859
|
)
|
||
|
Purchases of property and equipment
|
(868
|
)
|
|
(936
|
)
|
||
|
Net cash provided by (used in) investing activities
|
5,703
|
|
|
(1,621
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Proceeds from issuance of common stock under employee equity incentive plans
|
2,005
|
|
|
1,027
|
|
||
|
Other
|
—
|
|
|
(2
|
)
|
||
|
Net cash provided by financing activities
|
2,005
|
|
|
1,025
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
19,891
|
|
|
(6,654
|
)
|
||
|
Cash and cash equivalents - beginning of period
|
45,742
|
|
|
40,621
|
|
||
|
Cash and cash equivalents - end of period
|
$
|
65,633
|
|
|
$
|
33,967
|
|
|
Non-cash investing and financing activities:
|
|
|
|
||||
|
Inventory transfers to property and equipment
|
$
|
149
|
|
|
$
|
303
|
|
|
Purchases of property and equipment included in accounts payable
|
$
|
63
|
|
|
$
|
485
|
|
|
|
Three Months Ended
March 31, |
||
|
Customers
|
2020
|
|
2019
|
|
Customer A (a distribution channel partner)
|
*
|
|
13%
|
|
Customer B (a distribution channel partner)
|
17%
|
|
*
|
|
Customer C (a distribution channel partner)
|
16%
|
|
*
|
|
|
|
March 31, 2020
|
||
|
Operating leases
|
|
|||
|
Right-of-use assets:
|
|
|||
|
|
Other non-current assets
|
$
|
31,340
|
|
|
Total right-of-use assets
|
$
|
31,340
|
|
|
|
|
|
|
||
|
Lease liabilities:
|
|
|||
|
|
Accrued liabilities
|
$
|
4,716
|
|
|
|
Other non-current liabilities
|
26,871
|
|
|
|
Total operating lease liabilities
|
$
|
31,587
|
|
|
|
Remainder of 2020
|
$
|
4,230
|
|
|
|
2021
|
5,519
|
|
||
|
2022
|
4,659
|
|
||
|
2023
|
4,414
|
|
||
|
2024
|
4,518
|
|
||
|
Thereafter
|
11,773
|
|
||
|
Total lease payments
|
35,113
|
|
||
|
Less: imputed interest
|
(3,526
|
)
|
||
|
Present value of lease liabilities
|
$
|
31,587
|
|
|
|
|
|
Three Months Ended March 31, 2020
|
|
Three Months Ended March 31, 2019
|
||||
|
Operating lease costs
|
$
|
1,777
|
|
|
$
|
893
|
|
|
|
Short-term lease costs
|
158
|
|
|
137
|
|
|||
|
Total lease costs
|
$
|
1,935
|
|
|
$
|
1,030
|
|
|
|
|
|
|
|
|
||||
|
|
March 31, 2020
|
||
|
Weighted-average remaining term (years)
|
6.87
|
|
|
|
Weighted-average discount rate
|
3.14
|
%
|
|
|
|
|
Three Months Ended March 31, 2020
|
||
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|||
|
|
Operating cash flows from operating leases
|
$
|
1,665
|
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||||||||||||||||||||
|
|
|
Amortized Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Amortized Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
||||||||||||||||
|
Certificates of deposit
|
|
$
|
9,049
|
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
9,055
|
|
|
$
|
10,548
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
$
|
10,558
|
|
|
Corporate securities
|
|
51,041
|
|
|
53
|
|
|
(163
|
)
|
|
50,931
|
|
|
51,745
|
|
|
207
|
|
|
(1
|
)
|
|
51,951
|
|
||||||||
|
U.S. Treasury and agency securities
|
|
6,716
|
|
|
64
|
|
|
—
|
|
|
6,780
|
|
|
9,222
|
|
|
3
|
|
|
—
|
|
|
9,225
|
|
||||||||
|
Commercial paper
|
|
500
|
|
|
—
|
|
|
—
|
|
|
500
|
|
|
500
|
|
|
—
|
|
|
—
|
|
|
500
|
|
||||||||
|
Asset-backed securities
|
|
10,003
|
|
|
16
|
|
|
(12
|
)
|
|
10,007
|
|
|
11,914
|
|
|
32
|
|
|
—
|
|
|
11,946
|
|
||||||||
|
Total
|
|
$
|
77,309
|
|
|
$
|
139
|
|
|
$
|
(175
|
)
|
|
$
|
77,273
|
|
|
$
|
83,929
|
|
|
$
|
252
|
|
|
$
|
(1
|
)
|
|
$
|
84,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
Amortized Cost
|
|
Fair Value
|
||||
|
Less than 1 year
|
$
|
34,906
|
|
|
$
|
34,902
|
|
|
Mature in 1 - 3 years
|
42,403
|
|
|
42,371
|
|
||
|
Total
|
$
|
77,309
|
|
|
$
|
77,273
|
|
|
|
|
|
|
||||
|
|
Less Than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
March 31, 2020
|
Fair Value
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Gross Unrealized Losses
|
||||||||||||
|
Certificates of deposit
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,375
|
|
|
$
|
(1
|
)
|
|
$
|
2,375
|
|
|
$
|
(1
|
)
|
|
Corporate securities
|
15,751
|
|
|
(68
|
)
|
|
13,359
|
|
|
(94
|
)
|
|
29,110
|
|
|
(162
|
)
|
||||||
|
Asset-backed securities
|
1,372
|
|
|
(2
|
)
|
|
3,045
|
|
|
(10
|
)
|
|
4,417
|
|
|
(12
|
)
|
||||||
|
Total
|
$
|
17,123
|
|
|
$
|
(70
|
)
|
|
$
|
18,779
|
|
|
$
|
(105
|
)
|
|
$
|
35,902
|
|
|
$
|
(175
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Less Than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
December 31, 2019
|
Fair Value
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Gross Unrealized Losses
|
||||||||||||
|
Corporate securities
|
$
|
2,996
|
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,996
|
|
|
$
|
(1
|
)
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||||||||||
|
Cash
|
$
|
48,175
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
48,175
|
|
|
$
|
35,546
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,546
|
|
|
Cash equivalents
|
17,458
|
|
|
—
|
|
|
—
|
|
|
17,458
|
|
|
10,196
|
|
|
—
|
|
|
—
|
|
|
10,196
|
|
||||||||
|
Certificates of deposit
|
—
|
|
|
9,055
|
|
|
—
|
|
|
9,055
|
|
|
—
|
|
|
10,558
|
|
|
—
|
|
|
10,558
|
|
||||||||
|
Corporate securities
|
—
|
|
|
50,931
|
|
|
—
|
|
|
50,931
|
|
|
—
|
|
|
51,951
|
|
|
—
|
|
|
51,951
|
|
||||||||
|
U.S. Treasury and agency securities
|
—
|
|
|
6,780
|
|
|
—
|
|
|
6,780
|
|
|
—
|
|
|
9,225
|
|
|
—
|
|
|
9,225
|
|
||||||||
|
Commercial paper
|
—
|
|
|
500
|
|
|
—
|
|
|
500
|
|
|
—
|
|
|
500
|
|
|
—
|
|
|
500
|
|
||||||||
|
Asset-backed securities
|
—
|
|
|
10,007
|
|
|
—
|
|
|
10,007
|
|
|
—
|
|
|
11,946
|
|
|
—
|
|
|
11,946
|
|
||||||||
|
Total
|
$
|
65,633
|
|
|
$
|
77,273
|
|
|
$
|
—
|
|
|
$
|
142,906
|
|
|
$
|
45,742
|
|
|
$
|
84,180
|
|
|
$
|
—
|
|
|
$
|
129,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
|
||||||
|
Raw materials
|
$
|
9,829
|
|
|
$
|
9,495
|
|
|
Finished goods
|
10,935
|
|
|
12,889
|
|
||
|
Total inventory
|
$
|
20,764
|
|
|
$
|
22,384
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
|
|
|
|
|
||||
|
Prepaid expenses
|
$
|
4,514
|
|
|
$
|
6,163
|
|
|
Deferred contract acquisition costs
|
5,302
|
|
|
6,231
|
|
||
|
Other
|
2,702
|
|
|
2,673
|
|
||
|
Total prepaid expenses and other current assets
|
$
|
12,518
|
|
|
$
|
15,067
|
|
|
|
Useful Life
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
(in years)
|
|
|
|
|
||||
|
Equipment
|
1 - 5
|
|
$
|
23,483
|
|
|
$
|
22,702
|
|
|
Software
|
1 - 3
|
|
765
|
|
|
726
|
|
||
|
Furniture and fixtures
|
1 - 7
|
|
652
|
|
|
459
|
|
||
|
Leasehold improvements
|
Lease term
|
|
5,438
|
|
|
5,440
|
|
||
|
Construction in process
|
|
|
48
|
|
|
—
|
|
||
|
Property and equipment, gross
|
|
|
30,386
|
|
|
29,327
|
|
||
|
Less: accumulated depreciation
|
|
|
(22,924
|
)
|
|
(21,671
|
)
|
||
|
Property and equipment, net
|
|
|
$
|
7,462
|
|
|
$
|
7,656
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated Amortization
|
|
Net
|
|
Cost
|
|
Accumulated Amortization
|
|
Net
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Developed technology
|
$
|
5,050
|
|
|
$
|
(3,788
|
)
|
|
$
|
1,262
|
|
|
$
|
5,050
|
|
|
$
|
(3,535
|
)
|
|
$
|
1,515
|
|
|
Patents
|
2,936
|
|
|
(2,254
|
)
|
|
$
|
682
|
|
|
2,936
|
|
|
(2,146
|
)
|
|
790
|
|
|||||
|
Total intangible assets
|
$
|
7,986
|
|
|
$
|
(6,042
|
)
|
|
$
|
1,944
|
|
|
$
|
7,986
|
|
|
$
|
(5,681
|
)
|
|
$
|
2,305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Fiscal Year
|
|
|
|||||
|
Remainder of 2020
|
|
$
|
1,082
|
|
|||
|
2021
|
|
862
|
|
||||
|
Total
|
|
$
|
1,944
|
|
|||
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
|
|
|
||||
|
Accrued compensation and benefits
|
$
|
10,121
|
|
|
$
|
12,227
|
|
|
Accrued tax liabilities
|
2,987
|
|
|
4,354
|
|
||
|
Lease liability
|
4,716
|
|
|
5,109
|
|
||
|
Other
|
6,419
|
|
|
6,066
|
|
||
|
Total accrued liabilities
|
$
|
24,243
|
|
|
$
|
27,756
|
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
|
|
|
||||
|
Deferred revenue:
|
|
|
|
||||
|
Products
|
$
|
6,456
|
|
|
$
|
6,593
|
|
|
Services
|
94,822
|
|
|
94,571
|
|
||
|
Total deferred revenue
|
101,278
|
|
|
101,164
|
|
||
|
Less: current portion
|
(62,718
|
)
|
|
(62,233
|
)
|
||
|
Non-current portion
|
$
|
38,560
|
|
|
$
|
38,931
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
Stock-based compensation by type of award:
|
|
|
|
||||
|
Stock options
|
$
|
110
|
|
|
$
|
184
|
|
|
Stock awards
|
2,682
|
|
|
3,474
|
|
||
|
Employee stock purchase rights
|
248
|
|
|
238
|
|
||
|
|
$
|
3,040
|
|
|
$
|
3,896
|
|
|
|
|
|
|
||||
|
Stock-based compensation by category of expense:
|
|
|
|
||||
|
Cost of revenue
|
$
|
325
|
|
|
$
|
324
|
|
|
Sales and marketing
|
764
|
|
|
1,321
|
|
||
|
Research and development
|
1,006
|
|
|
1,331
|
|
||
|
General and administrative
|
945
|
|
|
920
|
|
||
|
|
$
|
3,040
|
|
|
$
|
3,896
|
|
|
|
|
|
|
||||
|
|
Number of Shares
(thousands)
|
|
Weighted-Average Exercise Price per Share
|
|
Weighted-Average Remaining Contractual Term
(years)
|
|
Aggregate Intrinsic Value
(thousands)
|
|||||
|
Outstanding as of December 31, 2019
|
3,702
|
|
|
$
|
5.57
|
|
|
|
|
|
||
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Exercised
|
(644
|
)
|
|
4.37
|
|
|
|
|
|
|||
|
Canceled
|
(171
|
)
|
|
6.29
|
|
|
|
|
|
|
||
|
Outstanding as of March 31, 2020
|
2,887
|
|
|
5.80
|
|
|
3.01
|
|
$
|
3,195
|
|
|
|
Vested and exercisable as of March 31, 2020
|
2,810
|
|
|
$
|
5.73
|
|
|
2.90
|
|
$
|
3,194
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Number of Shares
(thousands)
|
|
Weighted-Average Grant Date Fair Value per Share
|
|
Weighted-Average Remaining Vesting Term
(years)
|
|||
|
Nonvested as of December 31, 2019
|
6,148
|
|
|
$
|
6.59
|
|
|
|
|
Granted
|
132
|
|
|
5.75
|
|
|
|
|
|
Released
|
(486
|
)
|
|
6.42
|
|
|
|
|
|
Canceled
|
(511
|
)
|
|
6.67
|
|
|
|
|
|
Nonvested as of March 31, 2020
|
5,283
|
|
|
$
|
6.58
|
|
|
1.75
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
Basic and diluted net loss per share
|
|
|
|
||||
|
Numerator:
|
|
|
|
||||
|
Net loss
|
$
|
(297
|
)
|
|
$
|
(12,272
|
)
|
|
Denominator:
|
|
|
|
||||
|
Weighted-average shares outstanding - basic
|
78,061
|
|
|
74,809
|
|
||
|
Weighted-average shares outstanding - diluted
|
78,061
|
|
|
74,809
|
|
||
|
Net loss per share:
|
|
|
|
||||
|
Basic and diluted
|
$
|
0.00
|
|
|
$
|
(0.16
|
)
|
|
|
Three Months Ended March 31,
|
||||
|
|
2020
|
|
2019
|
||
|
Stock options, restricted stock units and employee stock purchase rights
|
8,182
|
|
|
9,997
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
Americas
|
$
|
25,438
|
|
|
$
|
21,133
|
|
|
Japan
|
17,641
|
|
|
13,152
|
|
||
|
Asia Pacific, excluding Japan
|
4,882
|
|
|
8,776
|
|
||
|
EMEA
|
5,803
|
|
|
7,229
|
|
||
|
Total revenue
|
$
|
53,764
|
|
|
$
|
50,290
|
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
United States
|
$
|
34,483
|
|
|
$
|
35,964
|
|
|
Japan
|
2,393
|
|
|
2,689
|
|
||
|
Other
|
1,926
|
|
|
2,017
|
|
||
|
Total
|
$
|
38,802
|
|
|
$
|
40,670
|
|
|
|
|
|
|
||||
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
|
Accounts receivable, net
|
$
|
42,862
|
|
|
$
|
53,566
|
|
|
Deferred revenue, current
|
62,718
|
|
|
62,233
|
|
||
|
Deferred revenue, non-current
|
38,560
|
|
|
38,931
|
|
||
|
|
|
March 31, 2020
|
||
|
|
|
|
||
|
Within 1 year
|
$
|
62,718
|
|
|
|
Next 2 to 3 years
|
29,673
|
|
||
|
Thereafter
|
8,887
|
|
||
|
|
Total
|
$
|
101,278
|
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
||||||||||||||||||||
|
|
Three Months Ended March 31,
|
|
|
|
|
|||||||||||||||
|
|
2020
|
|
2019
|
|
Increase (Decrease)
|
|||||||||||||||
|
|
Amount
|
|
Percent of Total Revenue
|
|
Amount
|
|
Percent of Total Revenue
|
|
Amount
|
|
Percent
|
|||||||||
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Products
|
$
|
30,736
|
|
|
57.2
|
%
|
|
$
|
28,230
|
|
|
56.1
|
%
|
|
$
|
2,506
|
|
|
8.9
|
%
|
|
Services
|
23,028
|
|
|
42.8
|
|
|
22,060
|
|
|
43.9
|
|
|
968
|
|
|
4.4
|
|
|||
|
Total revenue
|
53,764
|
|
|
100.0
|
|
|
50,290
|
|
|
100.0
|
|
|
3,474
|
|
|
6.9
|
|
|||
|
Cost of revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Products
|
6,941
|
|
|
12.9
|
|
|
7,516
|
|
|
15.0
|
|
|
(575
|
)
|
|
(7.7
|
)
|
|||
|
Services
|
5,201
|
|
|
9.7
|
|
|
4,734
|
|
|
9.4
|
|
|
467
|
|
|
9.9
|
|
|||
|
Total cost of revenue
|
12,142
|
|
|
22.6
|
|
|
12,250
|
|
|
24.4
|
|
|
(108
|
)
|
|
(0.9
|
)
|
|||
|
Gross profit
|
41,622
|
|
|
77.4
|
|
|
38,040
|
|
|
75.6
|
|
|
3,582
|
|
|
9.4
|
|
|||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Sales and marketing
|
20,621
|
|
|
38.4
|
|
|
24,483
|
|
|
48.7
|
|
|
(3,862
|
)
|
|
(15.8
|
)
|
|||
|
Research and development
|
15,315
|
|
|
28.5
|
|
|
16,166
|
|
|
32.1
|
|
|
(851
|
)
|
|
(5.3
|
)
|
|||
|
General and administrative
|
5,895
|
|
|
10.9
|
|
|
8,358
|
|
|
16.6
|
|
|
(2,463
|
)
|
|
(29.5
|
)
|
|||
|
Total operating expenses
|
41,831
|
|
|
77.8
|
|
|
49,007
|
|
|
97.4
|
|
|
(7,176
|
)
|
|
(14.6
|
)
|
|||
|
Loss from operations
|
(209
|
)
|
|
(0.4
|
)
|
|
(10,967
|
)
|
|
(21.8
|
)
|
|
10,758
|
|
|
(98.1
|
)
|
|||
|
Non-operating income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
(155
|
)
|
|
(0.3
|
)
|
|
155
|
|
|
(100.0
|
)
|
|||
|
Interest and other income (expense), net
|
231
|
|
|
0.4
|
|
|
(633
|
)
|
|
(1.3
|
)
|
|
864
|
|
|
136.5
|
|
|||
|
Total non-operating income (expense), net
|
231
|
|
|
0.4
|
|
|
(788
|
)
|
|
(1.6
|
)
|
|
1,019
|
|
|
129.3
|
|
|||
|
Income (loss) before provision for income taxes
|
22
|
|
|
—
|
|
|
(11,755
|
)
|
|
(23.4
|
)
|
|
11,777
|
|
|
(100.2
|
)
|
|||
|
Provision for income taxes
|
319
|
|
|
0.6
|
|
|
517
|
|
|
1.0
|
|
|
(198
|
)
|
|
(38.3
|
)
|
|||
|
Net loss
|
$
|
(297
|
)
|
|
(0.6
|
)%
|
|
$
|
(12,272
|
)
|
|
(24.4
|
)%
|
|
$
|
11,975
|
|
|
(97.6
|
)%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
Increase (Decrease)
|
|||||||||||||||
|
|
Amount
|
|
Percent of Total Revenue
|
|
Amount
|
|
Percent of Total Revenue
|
|
Amount
|
|
Percent
|
|||||||||
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Products
|
$
|
30,736
|
|
|
57
|
%
|
|
$
|
28,230
|
|
|
56
|
%
|
|
$
|
2,506
|
|
|
9
|
%
|
|
Services
|
23,028
|
|
|
43
|
|
|
22,060
|
|
|
44
|
|
|
968
|
|
|
4
|
|
|||
|
Total revenue
|
$
|
53,764
|
|
|
100
|
%
|
|
$
|
50,290
|
|
|
100
|
%
|
|
$
|
3,474
|
|
|
7
|
%
|
|
Revenue by geographic region:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Americas
|
$
|
25,438
|
|
|
47
|
%
|
|
$
|
21,133
|
|
|
42
|
%
|
|
$
|
4,305
|
|
|
20
|
%
|
|
Japan
|
17,641
|
|
|
33
|
|
|
13,152
|
|
|
26
|
|
|
4,489
|
|
|
34
|
|
|||
|
Asia Pacific, excluding Japan
|
4,882
|
|
|
9
|
|
|
8,776
|
|
|
18
|
|
|
(3,894
|
)
|
|
(44
|
)
|
|||
|
EMEA
|
5,803
|
|
|
11
|
|
|
7,229
|
|
|
14
|
|
|
(1,426
|
)
|
|
(20
|
)
|
|||
|
Total revenue
|
$
|
53,764
|
|
|
100
|
%
|
|
$
|
50,290
|
|
|
100
|
%
|
|
$
|
3,474
|
|
|
7
|
%
|
|
|
Three Months Ended March 31,
|
|
Increase (Decrease)
|
|||||||||||
|
|
2020
|
|
2019
|
|
Amount
|
|
Percent
|
|||||||
|
Cost of revenue:
|
|
|
|
|
|
|
|
|||||||
|
Products
|
$
|
6,941
|
|
|
$
|
7,516
|
|
|
$
|
(575
|
)
|
|
(7.7
|
)%
|
|
Services
|
5,201
|
|
|
4,734
|
|
|
467
|
|
|
9.9
|
|
|||
|
Total cost of revenue
|
$
|
12,142
|
|
|
$
|
12,250
|
|
|
$
|
(108
|
)
|
|
(0.9
|
)%
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
Increase (Decrease)
|
|||||||||||||||
|
|
Amount
|
|
Gross Margin
|
|
Amount
|
|
Gross Margin
|
|
Amount
|
|
Gross Margin
|
|||||||||
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Products
|
$
|
23,795
|
|
|
77.4
|
%
|
|
$
|
20,714
|
|
|
73.4
|
%
|
|
$
|
3,081
|
|
|
4.0
|
%
|
|
Services
|
17,827
|
|
|
77.4
|
|
|
17,326
|
|
|
78.5
|
|
|
501
|
|
|
(1.1
|
)
|
|||
|
Total gross profit
|
$
|
41,622
|
|
|
77.4
|
%
|
|
$
|
38,040
|
|
|
75.6
|
%
|
|
$
|
3,582
|
|
|
1.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
Three Months Ended March 31,
|
|
Increase (Decrease)
|
|||||||||||
|
|
2020
|
|
2019
|
|
Amount
|
|
Percent
|
|||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Sales and marketing
|
$
|
20,621
|
|
|
$
|
24,483
|
|
|
$
|
(3,862
|
)
|
|
(15.8
|
)%
|
|
Research and development
|
15,315
|
|
|
16,166
|
|
|
(851
|
)
|
|
(5.3
|
)
|
|||
|
General and administrative
|
5,895
|
|
|
8,358
|
|
|
(2,463
|
)
|
|
(29.5
|
)
|
|||
|
Total operating expenses
|
$
|
41,831
|
|
|
$
|
49,007
|
|
|
$
|
(7,176
|
)
|
|
(14.6
|
)%
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2020
|
|
2019
|
||||
|
Cash provided by (used in):
|
|
|
|
||||
|
Operating activities
|
$
|
12,183
|
|
|
$
|
(6,058
|
)
|
|
Investing activities
|
5,703
|
|
|
(1,621
|
)
|
||
|
Financing activities
|
2,005
|
|
|
1,025
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
$
|
19,891
|
|
|
$
|
(6,654
|
)
|
|
|
|
Total
|
|
Less Than 1 Year
|
|
1 to 3 Years
|
|
3 to 5 Years
|
|
More Than 5 Years
|
||||||||||
|
Operating leases
|
|
$
|
35,113
|
|
|
$
|
4,230
|
|
|
$
|
14,592
|
|
|
$
|
9,143
|
|
|
$
|
7,148
|
|
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
|
|
|
|
|
|
|
Fair Value as of
|
|
|
|
|
|
|
||||||||||||||
|
|
(150 BPS)
|
|
(100 BPS)
|
|
(50 BPS)
|
|
3/31/2020
|
|
50 BPS
|
|
100 BPS
|
|
150 BPS
|
||||||||||||||
|
Marketable securities
|
$
|
77,833
|
|
|
$
|
77,649
|
|
|
$
|
77,464
|
|
|
$
|
77,273
|
|
|
$
|
77,065
|
|
|
$
|
76,858
|
|
|
$
|
76,651
|
|
|
•
|
The impact of COVID-19 on our business and on the business of our customers and business partners, as well as on the economy in general;
|
|
•
|
fluctuations in and timing of purchases from, or loss of, large customers;
|
|
•
|
the budgeting cycles and purchasing practices of end-customers;
|
|
•
|
our ability to attract and retain new end-customers;
|
|
•
|
changes in demand for our products and services, including seasonal variations in customer spending patterns or cyclical fluctuations in our markets;
|
|
•
|
our reliance on shipments at the end of our quarters;
|
|
•
|
variations in product mix or geographic locations of our sales, which can affect the revenue we realize for those sales;
|
|
•
|
the timing and success of new product and service introductions by us or our competitors;
|
|
•
|
our ability to increase the size of our distribution channel and to maintain relationships with important distribution channel partners;
|
|
•
|
our ability to improve our overall sales productivity and successfully execute our marketing strategies;
|
|
•
|
the effect of currency exchange rates on our revenue and expenses;
|
|
•
|
the cost and potential outcomes of existing and future litigation;
|
|
•
|
expenses related to our facilities;
|
|
•
|
the effect of discounts negotiated by our largest end-customers for sales or pricing pressure from our competitors;
|
|
•
|
changes in the growth rate of the application networking or security markets or changes in market needs;
|
|
•
|
inventory write downs, which may be necessary for our older products when our new products are launched and adopted by our end-customers;
|
|
•
|
our ability to expand internationally and domestically; and
|
|
•
|
our third-party manufacturers’ and component suppliers’ capacity to meet our product demand forecasts on a timely basis, or at all.
|
|
•
|
Companies that sell products in the traditional ADC market, such as F5 Networks, Inc. (“F5 Networks”) and Citrix Systems, Inc. (“Citrix Systems”);
|
|
•
|
Companies that sell open source, software-only, cloud-based ADC services, such as Avi Networks Inc. (“Avi Networks”), NGINX Inc. (“NGiNX”), and HAProxy Technologies, Inc. (“HAProxy”) as well as many startups;
|
|
•
|
Companies that sell CGN products, which were originally designed for other networking purposes, such as edge routers and security appliances from vendors like Cisco Systems, Inc. (“Cisco Systems”), Juniper Networks, Inc. (“Juniper Networks”) and Fortinet, Inc. (“Fortinet”);
|
|
•
|
Companies that sell traditional DDoS protection products, such as Arbor Networks, Inc., a subsidiary of NetScout Systems, (“Arbor Networks”) and Radware, Ltd. (“Radware”);
|
|
•
|
Companies that sell SSL decryption and inspection products, such as Symantec Corporation (through its acquisition of Blue Coat Systems Inc. in 2016) and F5 Networks; and
|
|
•
|
Companies that sell certain network security products, including Secure Web Gateways, SSL Insight/SSL Intercept, data center firewalls and Office 365 proxy solutions.
|
|
•
|
longer operating histories;
|
|
•
|
the capacity to leverage their sales efforts and marketing expenditures across a broader portfolio of products and services at a greater range of prices including through selling at zero or negative margins;
|
|
•
|
the ability to incorporate functionality into existing products to gain business in a manner that discourages users from purchasing our products, including through product bundling or closed technology platforms;
|
|
•
|
broader distribution and established relationships with distribution channel partners in a greater number of worldwide locations;
|
|
•
|
access to larger end-customer bases;
|
|
•
|
the ability to use their greater financial resources to attract our research and development engineers as well as other employees of ours;
|
|
•
|
larger intellectual property portfolios; and
|
|
•
|
the ability to bundle competitive offerings with other products and services.
|
|
•
|
greater difficulty in enforcing contracts and accounts receivable collection and possible longer collection periods;
|
|
•
|
increased expenses incurred in establishing and maintaining office space and equipment for our international operations;
|
|
•
|
greater difficulty in recruiting local experienced personnel, and the costs and expenses associated with such activities;
|
|
•
|
general economic and political conditions in these foreign markets;
|
|
•
|
economic uncertainty around the world, including continued economic uncertainty as a result of the COVID-19 pandemic, sovereign debt issues in Europe and the United Kingdom’s exit from the European Union (commonly referred to as “Brexit”);
|
|
•
|
management communication and integration problems resulting from cultural and geographic dispersion;
|
|
•
|
risks associated with trade restrictions and foreign legal requirements, including the importation, certification, and localization of our products required in foreign countries;
|
|
•
|
greater risk of unexpected changes in regulatory practices, tariffs, and tax laws and treaties;
|
|
•
|
the uncertainty of protection for intellectual property rights in some countries;
|
|
•
|
greater risk of a failure of foreign employees to comply with both U.S. and foreign laws, including antitrust regulations, the U.S. Foreign Corrupt Practices Act (“FCPA”), and any trade regulations ensuring fair trade practices; and
|
|
•
|
heightened risk of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may impact financial results and result in restatements of, or irregularities in, financial statements.
|
|
•
|
disruption of our business;
|
|
•
|
distraction of our management and employees;
|
|
•
|
difficulty in recruiting, hiring, motivating, and retaining talented and skilled personnel;
|
|
•
|
difficulty in maintaining or negotiating and consummating new, business or strategic relationships or transactions;
|
|
•
|
increased stock price volatility; and
|
|
•
|
increased costs and advisory fees.
|
|
•
|
a loss of existing or potential end-customers or channel partners;
|
|
•
|
delayed or lost revenue;
|
|
•
|
a delay in attaining, or the failure to attain, market acceptance;
|
|
•
|
the expenditure of significant financial and product development resources in efforts to analyze, correct, eliminate, or work around errors or defects, to address and eliminate vulnerabilities, to remediate harms potentially caused by those vulnerabilities, or to identify and ramp up production with third-party providers;
|
|
•
|
an increase in warranty claims, or an increase in the cost of servicing warranty claims, either of which would adversely affect our gross margins;
|
|
•
|
harm to our reputation or brand; and
|
|
•
|
litigation, regulatory inquiries, or investigations that may be costly and further harm our reputation.
|
|
•
|
expenditures of significant financial and product development resources in efforts to analyze, correct, eliminate or work around errors and defects or to address and eliminate vulnerabilities;
|
|
•
|
loss of existing or potential end-customers or distribution channel partners;
|
|
•
|
delayed or lost revenue;
|
|
•
|
delay or failure to attain market acceptance;
|
|
•
|
indemnification obligations under our agreements with resellers, distributors and/or end-customers;
|
|
•
|
an increase in warranty claims compared with our historical experience or an increased cost of servicing warranty claims, either of which would adversely affect our gross margin; and
|
|
•
|
litigation, regulatory inquiries, or investigations that may be costly and harm our reputation.
|
|
•
|
changes in the valuation of our deferred tax assets and liabilities;
|
|
•
|
expected timing and amount of the release of tax valuation allowances;
|
|
•
|
expiration of, or detrimental changes in, research and development tax credit laws;
|
|
•
|
tax effects of stock-based compensation;
|
|
•
|
costs related to intercompany restructurings;
|
|
•
|
changes in tax laws, regulations, accounting principles or interpretations thereof;
|
|
•
|
future earnings being lower than anticipated in countries where we have lower statutory tax rates and higher than anticipated earnings in countries where we have higher statutory tax rates; or
|
|
•
|
examinations by US federal, state or foreign jurisdictions that disagree with interpretations of tax rules and regulations in regard to positions taken on tax filings.
|
|
•
|
announcements of new products, services or technologies, commercial relationships, acquisitions or other events by us or our competitors;
|
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
|
•
|
significant volatility in the market price and trading volume of technology companies in general and of companies in our industry;
|
|
•
|
fluctuations in the trading volume of our shares or the size of our public float;
|
|
•
|
actual or anticipated changes or fluctuations in our results of operations;
|
|
•
|
whether our results of operations meet the expectations of securities analysts or investors;
|
|
•
|
actual or anticipated changes in the expectations of investors or securities analysts;
|
|
•
|
litigation or investigations involving us, our industry, or both;
|
|
•
|
regulatory developments in the United States, foreign countries or both;
|
|
•
|
general economic conditions and trends;
|
|
•
|
major catastrophic events, including COVID-19, and the responses thereto;
|
|
•
|
sales of large blocks of our common stock; or
|
|
•
|
departures of key personnel.
|
|
•
|
the ability of our Board of Directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preference and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
|
|
•
|
the exclusive right of our Board of Directors to elect a director to fill a vacancy created by the expansion of our Board of Directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board of Directors;
|
|
•
|
a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;
|
|
•
|
the requirement that a special meeting of stockholders may be called only by the chairman of our Board of Directors, our Chief Executive Officer, our secretary, or a majority vote of our Board of Directors, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;
|
|
•
|
the ability of our Board of Directors, by majority vote, to amend the bylaws, which may allow our Board of Directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and
|
|
•
|
advance notice procedures with which stockholders must comply to nominate candidates to our Board of Directors or not to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us.
|
|
Exhibit
Number
|
|
Description
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on December 6, 2019)
|
|
3.2
|
|
Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on December 6, 2019)
|
|
31.1
|
|
|
|
31.2
|
|
|
|
32.1*
|
|
|
|
32.2*
|
|
|
|
101.INS
|
|
XBRL Instant Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Extension Labels Linkbase Document
|
|
101.PRE
|
|
XBRL Extension Presentation Linkbase Document
|
|
|
|
*
|
The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10‑Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of A10 Networks, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10‑Q, irrespective of any general incorporation language contained in such filing.
|
|
|
A10 NETWORKS, INC.
|
|
|
By: /s/ Dhrupad Trivedi
|
|
|
Dhrupad Trivedi
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
By: /s/ Tom Constantino
|
|
|
Tom Constantino
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Accounting and Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|